CoChat

Withdrawal syndrome after antipsychotics discontinuation: an analysis of the WHO database of spontaneous reports (Vigibase) between 2000 and 2022

Storck, Wilhelm, de Laportalière, Tanguy Taillefer, Yrondi, Antoine, Javelot, Hervé, Berna, Fabrice, Montastruc, François · 2024 · Psychopharmacology

The DOI matches its Crossref record; 18 of the 20 references it cites were found in a registry or an index.

Abstract

Rationale Withdrawal syndrome (WDS) has been described after discontinuation of antipsychotics. WDS could be the consequence of an over-activation of the dopaminergic pathway. Antipsychotics with a higher affinity for dopamine D2 receptors could be associated with a higher risk of WDS. This study aims to address this statement and evaluate the risk difference for withdrawal syndrome between antipsychotics based on pharmacovigilance data. Methods We collected individual reports registered in Vigibase® between 01/01/2000 and 31/12/2022 of patients treated with antipsychotics and who had presented WDS. A disproportionality analysis was performed to evaluate the risk of reporting WDS with each antipsychotic compared to all other antipsychotics. We performed a correlation analysis to assess the correlation between the risk of reporting WDS for each antipsychotic in relation with their pKi for D2 and 5HT2A receptors. Results The most frequent psychiatric withdrawal symptoms after antipsychotic discontinuation were insomnia, anxiety and depression. Tremor, headache and dizziness were among the most frequently reported neurologic withdrawal symptoms. Tiotixene had the highest risk of reporting WDS (ROR 7.08; 95%CI 3.49 - 14.35) followed by pimozide (ROR 4.35; 95%CI 1.93 - 9.77), quetiapine (ROR 4.24; 95%CI 3.87 - 4.64), thioridazine (ROR 4.17; 95%CI 2.50-6.98) and ziprasidone (ROR 2.98; 95%CI 2.41-3.67). We found a poor correlation between D2/5HT2A binding affinity and the risk of re…

Overview

Integrity signals

Registry

Crossref · 10.1007/s00213-024-06554-4

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 18 references

Cited by

Metadata

Authors
Storck, W., de Laportalière, T. T., Yrondi, A., Javelot, H., Berna, F., & Montastruc, F.
Affiliations
  • Centre Hospitalier Universitaire de Toulouse (FR)
  • Université de Strasbourg (FR)
  • Inserm (FR)
Corresponding author
Storck, Wilhelm
Venue
Psychopharmacology
Published
2024-02-20
Volume
241
Issue
6
Pages
1205-1212
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W4391981454
Cited by
10
References
20
Citations by year
2026: 7 · 2025: 2 · 2024: 1
FWCI
2.92
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
Keywords
antipsychotic discontinuation, pimozide, quetiapine, thioridazine, ziprasidone, withdrawal symptoms, pharmacovigilance, disproportionality analysis, adverse drug reactions, antipsychotic drugs, rebound
MeSH terms
Adult, Aged, Female, Humans, Male, Middle Aged, Substance Withdrawal Syndrome, Antipsychotic Agents, Databases, Factual, Adverse Drug Reaction Reporting Systems, Receptors, Dopamine D2, Young Adult, Pharmacovigilance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.